SMPDL3B contributes to gastric adenocarcinoma cells progression by promoting the infiltration of M2 macrophages
- 1Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.
- 2Department of Oncology, Tianjin Union Medical Center, Nankai University, Tianjin, China.
- 0Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Sphingomyelin phosphodiesterase acid-like 3b (SMPDL3B) is highly expressed in gastric adenocarcinoma (GAC), promoting tumor growth and invasion. Targeting SMPDL3B may offer new strategies for GAC diagnosis and treatment.
Area Of Science
- Oncology
- Molecular Biology
- Immunology
Background
- Gastric adenocarcinoma (GAC) presents significant morbidity and mortality, necessitating novel diagnostic markers and therapeutic targets.
- Sphingomyelin phosphodiesterase acid-like 3b (SMPDL3B) is investigated for its role in GAC progression.
Purpose Of The Study
- To investigate the expression of SMPDL3B in GAC.
- To determine the effects of SMPDL3B on GAC tumor progression.
Main Methods
- Analysis of GAC patient samples and cell lines (GES-1, SGC-7901, AGS, MGC-803, MSN-45).
- Techniques included RT-qPCR, Western blot, immunohistochemistry, cell proliferation, migration, invasion assays, flow cytometry, and immune evaluation.
- SMPDL3B knockdown and overexpression models were utilized.
Main Results
- SMPDL3B expression was significantly elevated in GAC, correlating with poor prognosis.
- SMPDL3B promoted GAC cell proliferation, migration, and invasion.
- Bioinformatics analysis revealed SMPDL3B's association with M2 macrophage infiltration in the GAC tumor microenvironment, enhancing proliferation.
Conclusions
- SMPDL3B plays a crucial role in GAC progression.
- SMPDL3B holds potential as a biomarker for GAC diagnosis and prognosis.
- Targeting SMPDL3B may represent a novel therapeutic strategy for GAC.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:07
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:23
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

